Role of the Latent Transforming Growth Factor β–Binding Protein 1 in Fibrillin‐Containing Microfibrils in Bone Cells In Vitro and In Vivo

Latent transforming growth factor β–binding proteins (LTBPs) are extracellular matrix (ECM) proteins that bind latent transforming growth factor β (TGF‐β) and influence its availability in bone and other connective tissues. LTBPs have homology with fibrillins and may have related functions as microfibrillar proteins. However, at present little is known about their structural arrangement in the ECM. By using antibodies against purified LTBP1, against a short peptide in LTBP1, and against epitope‐tagged LTBP1 constructs, we have shown colocalization of LTBP1 and fibrillin 1 in microfibrillar structures in the ECM of cultured primary osteoblasts. Immunoelectron microscopy confirmed localization of LTBP1 to 10‐ to 12‐nm microfibrils and suggested an ordered aggregation of LTBP1 into these structures. Early colocalization of LTBP1 with fibronectin suggested a role for fibronectin in the initial assembly of LTBP1 into the matrix; however, in more differentiated osteoblast cultures, LTBP1 and fibronectin 1 were found in distinct fibrillar networks. Overexpression of LTBP1 deletion constructs in osteoblast‐like cells showed that N‐terminal amino acids 67–467 were sufficient for incorporation into fibrillin‐containing microfibrils and suggested that LTBP1 can be produced by cells distant from the site of fibril formation. In embryonic long bones in vivo, LTBP1 and fibrillin 1 colocalized at the surface of newly forming osteoid and bone. However, LTBP1‐positive fibrils, which did not contain fibrillin 1, were present in cartilage matrix. These studies show that in addition to regulating TGFβ1, LTBP1 may function as a structural component of connective tissue microfibrils. LTBP1 may therefore be a candidate gene for Marfan‐related connective tissue disorders in which linkage to fibrillins has been excluded.

[1]  L. Bonewald,et al.  Growth plate chondrocytes store latent transforming growth factor (TGF)‐β1 in their matrix through latent TGF‐β1 binding protein‐1 , 1998 .

[2]  C. Heldin,et al.  Recombinant Latent Transforming Growth Factor β-binding Protein 2 Assembles to Fibroblast Extracellular Matrix and Is Susceptible to Proteolytic Processing and Release* , 1998, The Journal of Biological Chemistry.

[3]  O. Monni,et al.  Identification and Characterization of a New Latent Transforming Growth Factor-β-binding Protein, LTBP-4* , 1998, The Journal of Biological Chemistry.

[4]  A. Roberts Molecular and Cell Biology of TGF-β , 1998, Mineral and Electrolyte Metabolism.

[5]  H. Dietz,et al.  Targetting of the gene encoding fibrillin–1 recapitulates the vascular aspect of Marfan syndrome , 1997, Nature Genetics.

[6]  R. Timpl,et al.  Sequence and expression of a novel member (LTBP‐4) of the family of latent transforming growth factor‐β binding proteins , 1997 .

[7]  D. Rifkin,et al.  Latent Transforming Growth Factor-β Binding Protein Domains Involved in Activation and Transglutaminase-dependent Cross-Linking of Latent Transforming Growth Factor-β , 1997, The Journal of cell biology.

[8]  K. Miyazono,et al.  Extracellular Fibrillar Structure of Latent TGFβ Binding Protein-1: Role in TGFβ-dependent Endothelial-Mesenchymal Transformation during Endocardial Cushion Tissue Formation in Mouse Embryonic Heart , 1997, The Journal of cell biology.

[9]  Jussi Taipale,et al.  Growth factors in the extracellular matrix , 1997, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[10]  J. Taipale,et al.  Latent transforming growth factor-beta 1 and its binding protein are components of extracellular matrix microfibrils. , 1996, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[11]  F. Ramirez Fibrillln mutations in Marfan syndrome and related phenotypes. , 1996, Current opinion in genetics & development.

[12]  R. Mecham,et al.  Analysis of the human gene encoding latent transforming growth factor-beta-binding protein-2. , 1996, The international journal of biochemistry & cell biology.

[13]  L. Sandberg,et al.  Further Characterization of Proteins Associated with Elastic Fiber Microfibrils Including the Molecular Cloning of MAGP-2 (MP25) (*) , 1996, The Journal of Biological Chemistry.

[14]  J. Taipale,et al.  Association of the small latent transforming growth factor‐beta with an eight cysteine repeat of its binding protein LTBP‐1. , 1996, The EMBO journal.

[15]  G. Sutherland,et al.  Bovine latent transforming growth factor beta 1-binding protein 2: molecular cloning, identification of tissue isoforms, and immunolocalization to elastin-associated microfibrils , 1995, Molecular and cellular biology.

[16]  L. Bonewald,et al.  Dual role for the latent transforming growth factor-beta binding protein in storage of latent TGF-beta in the extracellular matrix and as a structural matrix protein , 1995, The Journal of cell biology.

[17]  R. Marcus,et al.  The bone mineral status of patients with marfan syndrome , 1995, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[18]  H. Dietz,et al.  Mutations in the human gene for fibrillin-1 (FBN1) in the Marfan syndrome and related disorders. , 1995, Human molecular genetics.

[19]  C. Kielty,et al.  Fibrillin-containing microfibrils: structure and function in health and disease. , 1995, The international journal of biochemistry & cell biology.

[20]  W. Hu,et al.  Developmental expression of fibrillin genes suggests heterogeneity of extracellular microfibrils , 1995, The Journal of cell biology.

[21]  R. Mecham,et al.  Isolation of a Novel Latent Transforming Growth Factor-β Binding Protein Gene (LTBP-3) (*) , 1995, The Journal of Biological Chemistry.

[22]  W. Argraves,et al.  A quantitative analysis of the incorporation of fibulin-1 into extracellular matrix indicates that fibronectin assembly is required. , 1995, Matrix biology : journal of the International Society for Matrix Biology.

[23]  K. Miyazono,et al.  Identification and characterization of LTBP-2, a novel latent transforming growth factor-beta-binding protein. , 1994, The Journal of biological chemistry.

[24]  Lynda F. Bonewald,et al.  Role of active and latent transforming growth factor β in bone formation , 1994 .

[25]  L. Bonewald,et al.  Characterization and autoregulation of latent transforming growth factor beta (TGF beta) complexes in osteoblast-like cell lines. Production of a latent complex lacking the latent TGF beta-binding protein. , 1994, The Journal of biological chemistry.

[26]  L. Bruckner-Tuderman,et al.  Versican is expressed in the proliferating zone in the epidermis and in association with the elastic network of the dermis , 1994, The Journal of cell biology.

[27]  R. Mecham,et al.  Structure and expression of fibrillin-2, a novel microfibrillar component preferentially located in elastic matrices , 1994, The Journal of cell biology.

[28]  K. Miyazono,et al.  Latent transforming growth factor-beta 1 associates to fibroblast extracellular matrix via latent TGF-beta binding protein , 1994, The Journal of cell biology.

[29]  T. Sasaki,et al.  Structure and expression of fibulin-2, a novel extracellular matrix protein with multiple EGF-like repeats and consensus motifs for calcium binding , 1993, The Journal of cell biology.

[30]  C. Haipek,et al.  Tartrate-resistant acid phosphatase gene expression as a facile reporter gene for screening transfection efficiency in mammalian cell cultures. , 1993, BioTechniques.

[31]  R. Glanville,et al.  The molecular basis of Marfan syndrome. , 1993, DNA and cell biology.

[32]  F. Ramirez,et al.  The fibrillin‐marfan syndrome connection , 1993, BioEssays : news and reviews in molecular, cellular and developmental biology.

[33]  A. Colombatti,et al.  Emilin, a component of elastic fibers preferentially located at the elastin-microfibrils interface , 1993, The Journal of cell biology.

[34]  K. Miyazono,et al.  Role of the latent TGF-beta binding protein in the activation of latent TGF-beta by co-cultures of endothelial and smooth muscle cells , 1993, The Journal of cell biology.

[35]  E. Ruoslahti,et al.  Transforming growth factor-beta in disease: the dark side of tissue repair. , 1992, The Journal of clinical investigation.

[36]  F. Fauvel-Lafève,et al.  Thrombospondin: a component of microfibrils in various tissues. , 1991, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[37]  R. Glanville,et al.  Purification and partial characterization of fibrillin, a cysteine-rich structural component of connective tissue microfibrils. , 1991, The Journal of biological chemistry.

[38]  L. Bonewald,et al.  Latent Forms of Transforming Growth Factor-β (TGFβ) Derived from Bone Cultures: Identification of a Naturally Occurring 100-kDa Complex with Similarity to Recombinant Latent TGFβ , 1991 .

[39]  I. D. Campbell,et al.  Key residues involved in calcium-binding motifs in EGF-like domains , 1991, Nature.

[40]  K. Miyazono,et al.  A role of the latent TGF‐beta 1‐binding protein in the assembly and secretion of TGF‐beta 1. , 1991, The EMBO journal.

[41]  K. Yamaguchi,et al.  Molecular cloning of the large subunit of transforming growth factor type beta masking protein and expression of the mRNA in various rat tissues. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[42]  K. Miyazono,et al.  TGF-β1 binding protein: A component of the large latent complex of TGF-β1 with multiple repeat sequences , 1990, Cell.

[43]  E. Ruoslahti,et al.  Fibulin, a novel protein that interacts with the fibronectin receptor β subunit cytoplasmic domain , 1989, Cell.

[44]  A. Brunner,et al.  Type 1 transforming growth factor beta: amplified expression and secretion of mature and precursor polypeptides in Chinese hamster ovary cells , 1987, Molecular and cellular biology.

[45]  M. Gibson,et al.  The immunohistochemical localisation of microfibril‐associated glycoprotein (MAGP) in elastic and non‐elastic tissues , 1987, Immunology and cell biology.

[46]  E. Engvall,et al.  Fibrillin, a new 350-kD glycoprotein, is a component of extracellular microfibrils , 1986, The Journal of cell biology.

[47]  O. Blumenfeld,et al.  Extracellular matrix microfibrils are composed of core proteins coated with fibronectin. , 1985, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[48]  P. McKeown-Longo,et al.  Assembly of fibronection‐containing extracellular matrix: A glimpse of the machinery , 1985, Biopolymers.

[49]  K. Miyazono,et al.  Latent Transforming Growth Factor-/ l Associates to Fibroblast Extracellular Matrix via Latent ' II 3 FB Binding Protein , 2002 .

[50]  L. Bonewald Regulation and regulatory activities of transforming growth factor beta. , 1999, Critical reviews in eukaryotic gene expression.

[51]  J. Taipale,et al.  Extracellular matrix-associated transforming growth factor-beta: role in cancer cell growth and invasion. , 1998, Advances in cancer research.

[52]  A. Roberts Molecular and cell biology of TGF-beta. , 1998, Mineral and electrolyte metabolism.

[53]  G Collod-Béroud,et al.  Marfan Database (second edition): software and database for the analysis of mutations in the human FBN1 gene , 1997, Nucleic Acids Res..

[54]  J. Wozney,et al.  Immortalized murine osteoblasts derived from BMP 2-T-antigen expressing transgenic mice. , 1996, Endocrinology.

[55]  D. Reinhardt,et al.  The structure and function of fibrillin. , 1995, Ciba Foundation symposium.

[56]  L. Bonewald,et al.  Latent forms of transforming growth factor-beta (TGF beta) derived from bone cultures: identification of a naturally occurring 100-kDa complex with similarity to recombinant latent TGF beta. , 1991, Molecular endocrinology.

[57]  S. Bruder,et al.  Cellular and molecular events during embryonic bone development. , 1989, Connective tissue research.